TABLE 2.
Correlations between capsular serotypes and clinical manifestations
| Clinical manifestation | Serotype (no. [%])a |
Total no. (%) | P value | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ia | Ib | II | III | V | VI | VIII | Othersb | |||
| STSSc | 2 | 2 (0.5) | ||||||||
| Necrotizing fasciitis | 2 | 1 | 1 | 1 | 5 (1.1) | |||||
| Meningitis | 2 (11.8) | 9 (52.9) | 3 (17.7) | 1 (5.9) | 1 (5.9) | 1 (5.9) | 17 (3.8) | 0.740 | ||
| Bacteremia without primary focus | 16 (7.2) | 98 (44.3) | 14 (6.3) | 27 (12.2) | 37 (16.7) | 21 (9.5) | 4 (1.8) | 4 (1.8) | 221 (49.9) | 0.158 |
| Endocarditis | 9 (53.0) | 4 (23.5) | 2 (11.8) | 1 (5.9) | 1 (5.9) | 17 (3.8) | 0.212 | |||
| Pneumonia | 4 (10.0) | 15 (37.5) | 4 (10.0) | 5 (12.5) | 3 (7.5) | 7 (17.5) | 2 (5.0) | 40 (9.0) | 0.504 | |
| Arthritis | 1 (7.1) | 3 (21.4) | 2 (14.3) | 3 (21.4) | 4 (28.6) | 1 (7.1) | 14 (3.2) | 0.522 | ||
| Osteomyelitis/spondylitis | 1 (7.7) | 3 (23.1) | 2 (15.4) | 3 (23.1) | 2 (15.4) | 1 (7.7) | 1 (7.7) | 13 (2.9) | 0.385 | |
| Cholangitis/peritonitis | 3 | 2 | 2 | 1 | 1 | 9 (2.0) | ||||
| Cellulitis | 4 (7.0) | 23 (40.4) | 2 (3.5) | 8 (14.0) | 12 (21.1) | 4 (7.0) | 4 (7.0) | 57 (12.9) | 0.584 | |
| Abscess, noncutaneous | 4 (15.4) | 9 (34.6) | 4 (15.4) | 6 (23.1) | 3 (11.5) | 26 (5.9) | 0.177 | |||
| Othersd | 1 (4.5) | 4 (18.2) | 4 (18.2) | 4 (18.2) | 3 (13.6) | 4 (18.2) | 2 (9.1) | 22 (5.0) | 0.142 | |
| Total no. (%) | 38 (8.6) | 175 (39.5) | 33 (7.4) | 61 (13.8) | 71 (16.0) | 42 (9.5) | 17 (3.8) | 6 (1.4) | 443 | |
a
Percentages are for each subtotal. Blank spaces indicate no cases.
b
Others include serotypes IV (n = 4), VII (n = 1), and nontypeable (n = 1).
c
Streptococcal toxic shock syndrome.
d
Others mostly consisted of erysipelas, lymphangitis, intrauterine infection, and discitis.